Interest of Measuring Microalbuminuria and Glycated Hemoglobin in Type 2 Diabetes in Mali Hospital
DOI:
https://doi.org/10.14738/ejas.1405.12083Keywords:
Type 2 Diabetes, Microalbuminuria, Glycated hemoglobin, Mali HospitalAbstract
Introduction: Diabetes is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Objective: The objective of this study was to investigate the correlation between microalbuminuria and glycated hemoglobin in the monitoring of patients with type 2 diabetes mellitus. Methods : This was a cross-sectional, descriptive, and analytical study conducted simultaneously in the Endocrinology Department and the Medical Biology Laboratory of Mali Hospital from February 1 to September 31, 2022. The study population consisted of patients with type 2 diabetes aged between 30 and 70 years. Results: A total of 160 patients with type 2 diabetes were included. Females predominated, with a male-to-female ratio of 0.74. The mean age of participants was 54.63 ± 10.16 years. The most prevalent diabetes risk factors were advanced age, overweight/obesity, hypertension, family history of diabetes, and dyslipidemia, with respective frequencies of 90.6%, 62.5%, 47.5%, 46.8%, and 35.6%. The mean biochemical parameters were 1.94 ± 0.93 g/L for fasting plasma glucose, 9.58 ± 3.19% for glycated hemoglobin, and 91.96 ± 119.19 mg/L for microalbuminuria. A statistically significant correlation was found between elevated fasting plasma glucose and the presence of microalbuminuria (p = 0.013). Microalbuminuria was also significantly higher in patients with elevated glycated hemoglobin levels (p = 0.01). Conclusion: Poor glycemic control and persistent positive microalbuminuria appear to be predictive markers for the development of microvascular complications in patients with type 2 diabetes.
References
International Diabetes Federetion. Diabetes around the world in 2021. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2022.
Diop SN, Diédhou D. Diabetes Mellitus in Sub-Saharan Africa: Epidemiological and Socioeconomic Aspects. Médecine des Maladies Métaboliques. 2015; Vol. 9(2): 123–129.
Sy S, Samaké M, Sy D, Coulibaly M, Diallo D, Yattara H et al., Prevalence of Micro- and Macroalbuminuria in Type 2 Diabetic Patients at the Point G University Teaching Hospital in Bamako. Health Sci. Dis. 2020; Vol. 21(3): 61–64.
WHO. Global Report on Diabetes: Executive Summary, 2016. Scholar Publishing
Diabetes Magazine. Links between Glycated Hemoglobin and Cardiovascular Disease. 2019.
Goulle J-P, Lacroix C, Bouige D. Glycated Hemoglobin: A Marker of Choice in Forensic Toxicology. Annals of Analytical Toxicology. 2000; Vol. XII, No. 3.
French Federation of Diabetics. HbA1c or Glycated Hemoglobin. 2010.
Weir MR. Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor. J Clin Hypertens (Greenwich). 2004 Mar;6(3):134-41.
Kamissoko K-F. Therapeutic Aspects of Type 2 Diabetes in the Internal Medicine and Endocrinology Department of the Mali Hospital [Medical Thesis]. Bamako: FMPOS Library; 2017.
Diawara MS, Cissé MM, Kane Y, Koney AK, Faye M, Fall K et al., Chronic Kidney Disease in the Thiès Region: Epidemiological, Clinico-Paraclinical, Therapeutic and Evolutionary Aspects: About 86 Cases Collected from 2013 to 2017. Health Sci Dis. 2019; 20(6): 58–62.
Yazdkhasti M, Jafarabady K, Shafiee A, Omran SP, Mahmoodi Z, Esmaeilzadeh S et al., The association between age of menopause and type 2 diabetes: a systematic review and metaanalysis. Nutr Metab (Lond). 2024;21(1):87.
Drissa S, Doumbia N, Coulibaly M, Cissé S, Mangara S, Berthé B et al., Epidemiological and Clinical Aspects of Diabetes Mellitus at the Internal Medicine Unit of Fousseyni Daou Hospital in Kayes, Mali. SAS J Med. Nov 2021; 7(11): 603–609.
Diao A. Assessment of Glycemic Control by Glycated Hemoglobin in Type 2 Diabetic Patients Followed in the Diabetology Unit of the Reference Health Center of Commune I of Bamako District [Medical Thesis]. Bamako: FMOS Library; 2020.
Kahina H, Asma M. Value of Microalbuminuria Measurement in the Early Diagnosis of Diabetic Nephropathy [Biology Thesis]. People’s Democratic Republic of Algeria; 2015.
Diop SN, Wade A, Lokrou A, Diédhiou D, Adoueni VK, et al., Management of type 2 diabetes in routine medical practice in sub-Saharan Africa: results of the AMAR-AFO study in Senegal and Côte d’Ivoire. Médecine des Maladies Métaboliques. 2013;7(4):363-367.
Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H. Epidemiology of diabetes in metropolitan France. Diabetes Metab. 2000;26(Suppl 6):11-24.
French National Authority for Health (HAS). Pharmacological strategy for glycemic control in type 2 diabetes: excerpt from the scientific rationale. Chapter: Epidemiology and cost of type 2 diabetes in France. Saint-Denis: HAS; 2013.
Robert P, O’Connor S, Perron L, Dubé M, Trépanier PL, Leclerc J. Overview of diabetes in the Quebec population aged one year and over from 2001 to 2019. Quebec: National Institute of Public Health of Quebec (INSPQ); 2022. (Chronic Disease Surveillance; No. 39).
Mossi KE, Balaka A, Tchamdja T, Djagadou KA, Sama HD, Apeti S, et al., Prevalence of complications of diabetes mellitus at the medical-surgical clinic of Sylvanus Olympio University Hospital in Lomé. Revue Africaine de Médecine Interne. 2019; 6(1-3):42-48.
Dawson C. Type II Diabetes Mellitus self-management: relating diabetes distress, social support, self-efficacy, and performance of diabetes self-care activities. [For the Degree of Master of Science]. Colorado State University. Fort Collins ; Colorado Spring 2020.
Diouf NN, Lo G, Sow-Ndoye A, Djité M, Diégane JAT, Diatta A. Evaluation of microalbuminuria and lipid profile in patients with type 2 diabetes. Rev Med Brux. 2015;36:10-13.
Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D. Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes. Nigerian Journal of Clinical Practice. 2013; Vol 16 : 2. Scholar Publishing
Chowta NK, Pant P, Chowta MN. Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearance. Indian J Nephrol. 2009; 19 (2) : 53-6.
Jatoi NA, Said AH, Al-Ghamdi MS, Al-Abdulmhsin MF, Bin-Jaban RA, Al-Tayeb JA et al., Prevalence of Microalbuminuria and Cardiovascular Risk Factors in Patients With Diabetes Mellitus Type-II in Al-Khobar, Kingdom of Saudi Arabia. Cureus. 2022 ; 14 (10) : e29808.
Diarra M. Value of microalbuminuria measurement in the early diagnosis of diabetic nephropathy in the diabetology department of Gabriel Touré University Hospital. [Medical thesis]. Bamako (Mali): Faculty of Medicine, Pharmacy and Odontology (FMPOS); 2009.
Lee CL, Li TC, Lin SY, Wang JS, Lee IT, Tseng LN et al., Dynamic and dual effects of glycated hemoglobin on estimated glomerular filtration rate in type 2 diabetic outpatients. Am J Nephrol. 2013; 38 (1) : 19-26.
Abdelwahid HA, Dahlan HM, Mojemamy GM, Darraj GH. Predictors of microalbuminuria and its relationship with glycemic control among Type 2 diabetic patients of Jazan Armed Forces Hospital, southwestern Saudi Arabia. BMC Endocr Disord. 2022 ; 22 (1) : 307.
Kare S, Reddy VN, Mahamkali T. A study to assess the correlation between HbA1c and microalbuminuria among diabetics. International Journal of Advances in Medicine. 2021; 8 (1) : 2349-3933.
Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose +control in development of renal end points in type 2 diabetes mellitus : systematic review and metaanalysis intensive glucose control in type 2 diabetes. Arch Intern Med. 2012; 172 (10) : 761-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Goïta Yaya, Afanou, Afi Emmanuella Clarisse, Amadou Koné, Dramé Boubacar, S. I., Doumbia Nanko, Théra Ali, Koné Adama, Kalambry Aimé C. , Dabo Abdoulaye, Diallo Mamadou, Coulibaly Djibril, M, Cissé Bakary, M.
This work is licensed under a Creative Commons Attribution 4.0 International License.
